Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatrics · Congenital Sideroblastic Anemia

Building Your Child's Care Team

At a Glance

Children with congenital sideroblastic anemia benefit from a coordinated team led by a pediatric hematologist, with genetics, primary care, and other specialists added for iron monitoring, transfusion support, hormone or heart concerns, and transplant planning when needed.

Because Congenital Sideroblastic Anemia (CSA) is a complex, rare disease, your child’s anemia plan must be led by specialists. However, your general pediatrician remains essential. The primary pediatrician manages immunizations, developmental milestones, common childhood illnesses, and provides crucial shared coordination. Together, your pediatrician and specialists form a “multidisciplinary team” that works to monitor iron levels and watch for any signs that the condition is affecting other parts of the body [1][2].

Your Core Care Team

The following specialists form the “home base” for a child with CSA:

  • Pediatric Hematologist (The Team Lead): This specialist directs the anemia care. They will manage blood counts, determine personalized transfusion thresholds, and oversee iron chelation therapy [3].
  • Medical Geneticist and Genetic Counselor: A geneticist is essential for confirming the exact subtype (such as SLC25A38 or ALAS2) [4]. A genetic counselor will help you understand the inheritance pattern, explain the specific recurrence risks for future children, and discuss testing options for siblings or family members [2][5].
  • Pediatric Care Coordinator: This person (often a nurse or social worker) helps schedule the many appointments, ensures all your doctors are talking to each other, and connects you with psychosocial support [1][6].

The “Specialty Circle”

Depending on your child’s specific gene mutation or how much iron has built up in their body, you may also need these experts:

  • Pediatric Cardiologist: Iron has a tendency to settle in the heart. While specialized imaging services perform the Cardiac T2* MRI, the cardiologist assesses cardiac function and helps manage any findings [7][8].
  • Pediatric Endocrinologist: Excess iron can affect the glands that produce hormones. This specialist monitors growth, bone health, and blood sugar levels [9][10].
  • Pediatric Transplant Specialist: If your child has a severe, transfusion-dependent form of CSA, an early referral to a transplant team is recommended [3]. They can explain the individualized risks and benefits of a stem cell transplant and assess donor options [11].

Preparing for the First Visit

When you meet a new specialist, you are your child’s most important historian. Bringing an organized “specialist packet” can help the doctor make faster, more accurate decisions [1].

Essential Records to Bring:

  • Complete Blood Counts (CBCs): Every CBC report your child has ever had, which shows the trends in their hemoglobin and cell size [12].
  • Genetic Test Results: The full laboratory report (not just a summary), which lists the specific mutations or VUS found [13].
  • Iron and Bone Marrow Reports: Results for ferritin, iron studies, and any bone marrow aspirate reports that mention “ring sideroblasts” [14][8].
  • Growth and Development Charts: Your child’s height and weight history from the pediatrician’s office [15].
  • Family History: A “family tree” that notes any relatives with anemia, unexplained heart or liver disease, or early childhood deaths [2].

Staying Coordinated

In the world of rare disease, information can easily get lost between different hospital systems. Ask your lead hematologist for a shared care plan—a written document that outlines who is responsible for which tests, when they should happen, and exactly what to do (and who to call after hours) in an emergency [1][16]. Having this “road map” ensures that everyone is moving in the same direction toward your child’s health.

Common questions in this guide

Who should be on my child's congenital sideroblastic anemia care team?
A pediatric hematologist usually leads care, while the child's general pediatrician remains important for routine health and coordination. A medical geneticist, genetic counselor, and care coordinator are also commonly involved. Cardiology, endocrinology, or transplant specialists may be added based on iron buildup, disease severity, and treatment needs.
What records should I bring to my child's first CSA specialist visit?
Bring all available complete blood counts, the full genetic testing report, iron studies and ferritin results, and any bone marrow reports. Growth charts and a family history that notes anemia, heart or liver disease, or early deaths can also help the team understand your child's history.
Why does my child with CSA need a genetic counselor?
A genetic counselor can explain your child's specific genetic result, how the condition may be inherited, and the chance it could affect future children. They can also discuss whether siblings or other relatives should have genetic testing.
How is iron buildup monitored in a child with congenital sideroblastic anemia?
The hematology team monitors blood tests and may use iron chelation treatment when appropriate. A cardiologist can assess heart function, including results from specialized heart MRI, while an endocrinologist may monitor growth, bone health, and blood sugar.
When should my child see a transplant specialist for CSA?
Early consultation is recommended when a child has a severe, transfusion-dependent form of congenital sideroblastic anemia. The transplant team can review the child's individual risks and benefits of stem cell transplant and assess possible donors; a consultation does not mean a transplant will definitely be needed.
How can I keep my child's CSA specialists coordinated?
Ask the lead hematologist for a written shared care plan that lists each clinician's responsibilities, the schedule for tests, and who to call after hours. Keep copies of laboratory results, genetic reports, growth charts, and the plan in one organized folder or digital file.

Get notified when new evidence is published on Severe congenital hypochromic anemia with ringed sideroblasts.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Multidisciplinary Care of Patients with Inherited Metabolic Diseases and Epilepsy: Current Perspectives.

    Tumienė B, Del Toro Riera M, Grikiniene J, et al.

    Journal of multidisciplinary healthcare 2022; (15()):553-566 doi:10.2147/JMDH.S251863.

    PMID: 35387391
  2. 2

    Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.

    Abu-Zeinah G, DeSancho MT

    Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.

    PMID: 33061728
  3. 3

    Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.

    Uminski K, Houston DS, Hartley JN, et al.

    Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.

    PMID: 32790119
  4. 4

    Rare anemias due to genetic iron metabolism defects.

    Brissot P, Bernard DG, Brissot E, et al.

    Mutation research. Reviews in mutation research 2018; (777()):52-63 doi:10.1016/j.mrrev.2018.06.003.

    PMID: 30115430
  5. 5

    A novel frameshift deletion in SLC25A38 and its role in mitochondrial dysfunction: A case study of sideroblastic anemia in a child from Iran.

    Hasani E, Naghinejad M, Kohkalani M, et al.

    Annals of hematology 2026; (105(4)):128.

    PMID: 41714435
  6. 6

    Developing a taxonomy of care coordination for people living with rare conditions: a qualitative study.

    Walton H, Simpson A, Ramsay AIG, et al.

    Orphanet journal of rare diseases 2022; (17(1)):171 doi:10.1186/s13023-022-02321-w.

    PMID: 35443702
  7. 7

    Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.

    Sommerville EW, Ng YS, Alston CL, et al.

    JAMA neurology 2017; (74(6)):686-694 doi:10.1001/jamaneurol.2016.4357.

    PMID: 28395030
  8. 8

    Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.

    Le Rouzic MA, Fouquet C, Leblanc T, et al.

    Blood cells, molecules & diseases 2017; (66()):11-18 doi:10.1016/j.bcmd.2017.07.003.

    PMID: 28772256
  9. 9

    IARS2-related disease manifesting as sideroblastic anemia and hypoparathyroidism: A case report.

    Gong Y, Lan XP, Guo S

    Frontiers in pediatrics 2022; (10()):1080664 doi:10.3389/fped.2022.1080664.

    PMID: 36704128
  10. 10

    Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations.

    Cao M, Donà M, Valentino ML, et al.

    Neurogenetics 2016; (17(1)):65-70 doi:10.1007/s10048-015-0465-x.

    PMID: 26556812
  11. 11

    Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience.

    Shamsian BS, Jafari MR, Abolghasemi H, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2023; (21(1)):70-75 doi:10.6002/ect.2022.0081.

    PMID: 36757170
  12. 12

    Sideroblastic anemia in children: challenges in diagnosis and management in three cases.

    Rekaya S, Ben Fraj I, Hamdi R, et al.

    Annals of hematology 2025; (104(4)):2537-2543 doi:10.1007/s00277-025-06266-5.

    PMID: 40042629
  13. 13

    [Clinical features and gene mutation spectrum in children with sideroblastic anemia].

    An WB, An WB, Liu C, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(10)):1016-1021.

    PMID: 31642437
  14. 14

    A novel and apparent de novo ALAS2 missense variant associated with congenital sideroblastic anemia.

    Cai J, Liu T, Huang Y, et al.

    Frontiers in pediatrics 2024; (12()):1411676 doi:10.3389/fped.2024.1411676.

    PMID: 39281190
  15. 15

    Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors.

    Giannelou A, Wang H, Zhou Q, et al.

    Annals of the rheumatic diseases 2018; (77(4)):612-619 doi:10.1136/annrheumdis-2017-212401.

    PMID: 29358286
  16. 16

    Validation of New Care Coordination Quality Measures for Children with Medical Complexity.

    Parast L, Burkhart Q, Gidengil C, et al.

    Academic pediatrics 2018; (18(5)):581-588 doi:10.1016/j.acap.2018.03.006.

    PMID: 29550397

This page is for informational purposes only and does not constitute medical advice. Your child's hematologist and care team should tailor testing, treatment, and emergency guidance to your child.

Guide contents Severe congenital hypochromic anemia with ringed sideroblasts
Research & Literature
05 Managing Iron Overload and Long-Term Monitoring